Article
Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients.
International journal of chronic obstructive pulmonary disease - 1 Jan 2018
Lim Jeong Uk, Yeo Chang Dong, Rhee Chin Kook, Kim Yong Hyun, Park Chan Kwon, Kim Ju Sang, Kim Jin Woo, Kim Seung Joon, Yoon Hyoung Kyu, Lee Sang Haak
Abstract excerpt
Objectives: Focusing on the advanced non-small cell lung cancer (NSCLC) patients without driver mutations can elucidate the clinical impact of COPD on treatment outcomes. The present study evaluated the effects of COPD on the overall survival of driver mutation-negative NSCLC patients undergoing conventional chemotherapy as the first-line treatment. Patients and methods: Medical records of stage IIIB and IV NSCLC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
